预测准确度 HeartMate 3 心脏移植后的风险评分 心脏移植后的风险评分 分配变化
Justin D Vincent1, Alyssa Ramsay2, David S Lambert1
1From the Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri.
概括
需要更新HeartMate 3风险评分 (HM3RS). 它没有准确地预测在现实环境中植入左心室辅助器件后患者的结果.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 研究成果 研究成果 研究成果
背景情况:
- 该HeartMate 3风险评分 (HM3RS) 是为了预测左心室辅助器件 (LVAD) 植入后的死亡率而开发的.
- 在现实人口中缺乏验证,特别是在最近对心脏移植分配的变化之后.
研究的目的:
- 在当代,现实世界的人口中验证HM3RS.
- 评估评分对LVAD植入后1年和2年的结果的预测准确性.
主要方法:
- 对接受HeartMate 3 LVAD的患者进行了多中心回顾性分析.
- 评估HM3RS在预测1年和2年死亡率方面的表现.
主要成果:
- 在当代的现实世界队列中,HM3RS没有准确预测1年和2年的结果.
- 在当前的临床环境中,得分的预测效用似乎减少了.
结论:
- HM3RS需要修订,以准确反映当前时代的结果.
- 对于接受HeartMate 3 LVADs的患者,需要一个新的风险预测工具.
相关概念视频
Bone Marrow Sampling and Transplants
292
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
292
Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341


